Protagonist Therapeutics Inc (PTGX)
Inventory turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | — | 3,312 | 1,032 | 2,775 | — |
Inventory | US$ in thousands | — | -10,332 | -94 | 8,503 | 3,976 |
Inventory turnover | — | — | — | 0.33 | 0.00 |
December 31, 2024 calculation
Inventory turnover = Cost of revenue ÷ Inventory
= $—K ÷ $—K
= —
Protagonist Therapeutics Inc's inventory turnover has shown a significant improvement from 0.00 in December 2020 to 0.33 in December 2021. The increase indicates that the company is managing its inventory more efficiently, selling its products more frequently or turning over its inventory more quickly. However, the lack of data for the subsequent years (2022, 2023, and 2024) makes it challenging to assess the trend over time. It is crucial for the company to continue monitoring and improving its inventory turnover to optimize its working capital and enhance overall operational efficiency.
Peer comparison
Dec 31, 2024
Company name
Symbol
Inventory turnover
Protagonist Therapeutics Inc
PTGX
—
Abbott Laboratories
ABT
3.02
AbbVie Inc
ABBV
4.04
ACADIA Pharmaceuticals Inc
ACAD
3.73
Alkermes Plc
ALKS
4.88
Amphastar P
AMPH
2.33
ANI Pharmaceuticals Inc
ANIP
1.83
Arcus Biosciences Inc
RCUS
—
Biomarin Pharmaceutical Inc
BMRN
0.47
Bristol-Myers Squibb Company
BMY
12.42
Catalyst Pharmaceuticals Inc
CPRX
3.52